Arkolith/Insider Trading/OCUP/Form 4

Benton Susan

DirectorOcuphire Pharma, Inc. (OCUP) · full profile →Form 4 · filed Jul 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2022Grant(A)6K——39K
Jul 1, 2022Grant(A)12K——51K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-025289) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML